Financhill
Sell
1

MEDX Quote, Financials, Valuation and Earnings

Last price:
$26.49
Seasonality move :
0.55%
Day range:
$26.41 - $26.60
52-week range:
$26.41 - $32.00
Dividend yield:
1.9%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
790
Avg. volume:
2K
1-year change:
-6.11%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    Horizon Kinetics Medical ETF has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of --, Horizon Kinetics Medical ETF has an estimated downside of -- from its current price of $26.48.
  • Price Target Upside
    According to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $26.48.

Fair Value

  • According to the consensus of 0 analysts, Horizon Kinetics Medical ETF has -- downside to fair value with a price target of -- per share.

MEDX vs. S&P 500

  • Over the past 5 trading days, Horizon Kinetics Medical ETF has overperformed the S&P 500 by 0.33% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Horizon Kinetics Medical ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Horizon Kinetics Medical ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Horizon Kinetics Medical ETF reported revenues of --.

Earnings Growth

  • Horizon Kinetics Medical ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Horizon Kinetics Medical ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-28 2023-12-28 2023-12-28
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2020-12-28 2021-12-28 2022-12-28 2023-12-28
Balance Sheet
Current Assets -- -- -- -- --
Total Assets -- -- -- -- --
Current Liabilities -- -- -- -- --
Total Liabilities -- -- -- -- --
Total Equity -- -- -- -- --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-28 2023-12-28 2023-12-28
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
MEDX
Sector
Market Cap
--
--
Price % of 52-Week High
82.74%
--
Dividend Yield
1.9%
--
Shareholder Yield
--
--
1-Year Price Total Return
-6.11%
--
Beta (5-Year)
--
--
Dividend yield:
1.9%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $26.86
200-day SMA
Sell
Level $29.51
Bollinger Bands (100)
Sell
Level 28.21 - 31.33
Chaikin Money Flow
Sell
Level -454.9K
20-day SMA
Sell
Level $27.70
Relative Strength Index (RSI14)
Sell
Level 29.39
ADX Line
Sell
Level 15.65
Williams %R
Buy
Level -96.8939
50-day SMA
Sell
Level $28.55
MACD (12, 26)
Sell
Level -0.54
25-day Aroon Oscillator
Sell
Level -56
On Balance Volume
Sell
Level -20.6K

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (6)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Stock Forecast FAQ

In the current month, MEDX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MEDX average analyst price target in the past 3 months is --.

  • Where Will Horizon Kinetics Medical ETF Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Horizon Kinetics Medical ETF share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Horizon Kinetics Medical ETF?

    Analysts are divided on their view about Horizon Kinetics Medical ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Horizon Kinetics Medical ETF is a Sell and believe this share price will rise from its current level to --.

  • What Is Horizon Kinetics Medical ETF's Price Target?

    The price target for Horizon Kinetics Medical ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MEDX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Horizon Kinetics Medical ETF is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of MEDX?

    You can purchase shares of Horizon Kinetics Medical ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Horizon Kinetics Medical ETF shares.

  • What Is The Horizon Kinetics Medical ETF Share Price Today?

    Horizon Kinetics Medical ETF was last trading at $26.49 per share. This represents the most recent stock quote for Horizon Kinetics Medical ETF. Yesterday, Horizon Kinetics Medical ETF closed at $26.48 per share.

  • How To Buy Horizon Kinetics Medical ETF Stock Online?

    In order to purchase Horizon Kinetics Medical ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
50
LMND alert for Dec 28

Lemonade [LMND] is down 10.69% over the past day.

Sell
50
TSLL alert for Dec 28

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.

Buy
63
SMLR alert for Dec 28

Semler Scientific [SMLR] is down 9.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock